Avalon Investment & Advisory - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 276 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 2.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
Avalon Investment & Advisory ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$3,419,000
-9.4%
67,899
+7.6%
0.10%
-14.3%
Q2 2018$3,775,000
+121.0%
63,075
+69.2%
0.11%
+111.3%
Q1 2018$1,708,000
+27.0%
37,289
+10.4%
0.05%
+26.2%
Q4 2017$1,345,000
+3.1%
33,764
+3.5%
0.04%0.0%
Q3 2017$1,305,000
-7.9%
32,632
-0.8%
0.04%
-10.6%
Q2 2017$1,417,000
+57.4%
32,879
+14.3%
0.05%
+51.6%
Q1 2017$900,00028,7650.03%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q3 2017
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 698,676$41,816,0005.51%
Provident Investment Management, Inc. 543,194$32,510,0004.61%
NEUMEIER POMA INVESTMENT COUNSEL LLC 426,250$25,511,0002.37%
KOPP INVESTMENT ADVISORS LLC 41,879$2,506,0002.35%
AlphaOne Investment Services, LLC 126,279$7,558,0002.17%
Ranger Investment Management 468,933$28,066,0001.96%
Bruce & Co., Inc. 158,058$9,459,0001.88%
Penserra Capital Management LLC 244,371$29,030,0001.83%
SHAKER INVESTMENTS LLC/OH 49,642$2,971,0001.83%
Bridge City Capital, LLC 47,795$2,861,0001.81%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders